Amy E. Lovett‐Racke

7.7k total citations
90 papers, 5.0k citations indexed

About

Amy E. Lovett‐Racke is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Amy E. Lovett‐Racke has authored 90 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Immunology, 26 papers in Molecular Biology and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Amy E. Lovett‐Racke's work include T-cell and B-cell Immunology (37 papers), Immunotherapy and Immune Responses (31 papers) and Multiple Sclerosis Research Studies (18 papers). Amy E. Lovett‐Racke is often cited by papers focused on T-cell and B-cell Immunology (37 papers), Immunotherapy and Immune Responses (31 papers) and Multiple Sclerosis Research Studies (18 papers). Amy E. Lovett‐Racke collaborates with scholars based in United States, Canada and Croatia. Amy E. Lovett‐Racke's co-authors include Michael K. Racke, Yuhong Yang, Rehana Z. Hussain, Mireia Guerau‐de‐Arellano, Paul D. Drew, Haiyan Peng, Robert B. Ratts, Asim Diab, Anne R. Gocke and Nitin J. Karandikar and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Amy E. Lovett‐Racke

89 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Lovett‐Racke United States 41 2.7k 1.7k 1.5k 752 730 90 5.0k
Sawsan Youssef United States 30 2.4k 0.9× 1.4k 0.8× 954 0.7× 853 1.1× 355 0.5× 46 5.2k
Eva Tolosa Germany 36 2.5k 0.9× 1.5k 0.9× 534 0.4× 788 1.0× 436 0.6× 98 5.5k
Stefan Brocke United States 36 2.9k 1.1× 1.2k 0.7× 930 0.6× 1.2k 1.6× 225 0.3× 76 5.2k
Chander Raman United States 37 1.8k 0.7× 1.2k 0.7× 961 0.7× 703 0.9× 166 0.2× 96 4.4k
Gopal Murugaiyan United States 30 2.0k 0.7× 1.1k 0.7× 350 0.2× 580 0.8× 624 0.9× 44 4.0k
Maja Jagodic Sweden 32 1.0k 0.4× 1.3k 0.8× 685 0.5× 362 0.5× 472 0.6× 101 3.0k
Shohreh Issazadeh‐Navikas Denmark 32 1.9k 0.7× 941 0.6× 539 0.4× 726 1.0× 201 0.3× 76 3.9k
Peggy P. Ho United States 31 1.2k 0.5× 1.3k 0.8× 597 0.4× 382 0.5× 155 0.2× 55 3.7k
David E. Szymkowski United States 33 1.0k 0.4× 1.5k 0.9× 339 0.2× 509 0.7× 238 0.3× 66 3.5k
Calliope A. Dendrou United Kingdom 15 1.3k 0.5× 872 0.5× 855 0.6× 326 0.4× 153 0.2× 32 2.9k

Countries citing papers authored by Amy E. Lovett‐Racke

Since Specialization
Citations

This map shows the geographic impact of Amy E. Lovett‐Racke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Lovett‐Racke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Lovett‐Racke more than expected).

Fields of papers citing papers by Amy E. Lovett‐Racke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Lovett‐Racke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Lovett‐Racke. The network helps show where Amy E. Lovett‐Racke may publish in the future.

Co-authorship network of co-authors of Amy E. Lovett‐Racke

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Lovett‐Racke. A scholar is included among the top collaborators of Amy E. Lovett‐Racke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Lovett‐Racke. Amy E. Lovett‐Racke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yue, et al.. (2024). MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function. European Journal of Immunology. 54(6). e2350548–e2350548. 1 indexed citations
2.
Lovett‐Racke, Amy E., et al.. (2023). miRNAs targeting TGFβ-signaling disrupt Treg development and function in CNS autoimmunity. The Journal of Immunology. 210(Supplement_1). 170.12–170.12. 1 indexed citations
3.
Gombash, Sara E., et al.. (2022). Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?. Frontiers in Neurology. 13. 796933–796933. 30 indexed citations
4.
Dorsett, Yair, Claudia Cantoni, Laura Ghezzi, et al.. (2021). Alterations of the gut mycobiome in patients with MS. EBioMedicine. 71. 103557–103557. 53 indexed citations
5.
Yang, Xiaozhi, Jinhua Song, Wei Pei, et al.. (2021). A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg Balance. JCI Insight. 6(4). 23 indexed citations
6.
Lovett‐Racke, Amy E.. (2016). Contribution of EAE to understanding and treating multiple sclerosis. Journal of Neuroimmunology. 304. 40–42. 17 indexed citations
7.
Fenn, Ashley M., Kristen M. Smith, Amy E. Lovett‐Racke, et al.. (2013). Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand. Neurobiology of Aging. 34(12). 2748–2758. 71 indexed citations
8.
Guerau‐de‐Arellano, Mireia, Kristen M. Smith, Jakub Godlewski, et al.. (2011). Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain. 134(12). 3578–3589. 169 indexed citations
9.
Huss, David, Ryan C. Winger, Haiyan Peng, et al.. (2010). TGF-β Enhances Effector Th1 Cell Activation but Promotes Self-Regulation via IL-10. The Journal of Immunology. 184(10). 5628–5636. 38 indexed citations
10.
Lovett‐Racke, Amy E., Yuhong Yang, & Michael K. Racke. (2010). Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(2). 246–251. 167 indexed citations
11.
Lovett‐Racke, Amy E., et al.. (2008). Monoclonal Antibody Therapies and Neurologic Disorders. Archives of Neurology. 65(9). 1162–5. 14 indexed citations
12.
Racke, Michael K. & Amy E. Lovett‐Racke. (2008). What are new therapies teaching us about the immunology of multiple sclerosis?. Therapy. 5(5). 589–591.
13.
Gocke, Anne R., Petra D. Cravens, Li-Hong Ben, et al.. (2007). T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity. The Journal of Immunology. 178(3). 1341–1348. 216 indexed citations
14.
Lovett‐Racke, Amy E., Rehana Z. Hussain, Judy Choy, et al.. (2004). Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease. The Journal of Immunology. 172(9). 5790–5798. 184 indexed citations
15.
Lovett‐Racke, Amy E., A. Rocchini, Judy Choy, et al.. (2004). Silencing T-bet Defines a Critical Role in the Differentiation of Autoreactive T Lymphocytes. Immunity. 21(5). 719–731. 153 indexed citations
16.
Deng, Caishu, Alfredo Minguela, Rehana Z. Hussain, et al.. (2002). Expression of the Tyrosine Phosphatase Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 Determines T Cell Activation Threshold and Severity of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 168(9). 4511–4518. 33 indexed citations
17.
Lovett‐Racke, Amy E. & Michael K. Racke. (2002). Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells. Cellular Immunology. 215(1). 54–60. 47 indexed citations
18.
Frohman, E., Nancy Monson, Amy E. Lovett‐Racke, & Michael K. Racke. (2001). Autonomic Regulation of Neuroimmunological Responses: Implications for Multiple Sclerosis. Journal of Clinical Immunology. 21(2). 61–73. 17 indexed citations
19.
Lovett‐Racke, Amy E., John L. Trotter, Jörg Lauber, et al.. (1998). Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.. Journal of Clinical Investigation. 101(4). 725–730. 224 indexed citations
20.
Racke, Michael K. & Amy E. Lovett‐Racke. (1998). Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur?. Research in Immunology. 149(9). 820–827. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sawsan Youssef Breakdown of academic impact, for papers by Eva Tolosa Breakdown of academic impact, for papers by Stefan Brocke Breakdown of academic impact, for papers by Chander Raman Breakdown of academic impact, for papers by Gopal Murugaiyan Breakdown of academic impact, for papers by Maja Jagodic Breakdown of academic impact, for papers by Shohreh Issazadeh‐Navikas Breakdown of academic impact, for papers by Peggy P. Ho Breakdown of academic impact, for papers by David E. Szymkowski Breakdown of academic impact, for papers by Calliope A. Dendrou
Rankless by CCL
2026